Shareholder plans to reduce stake in Kingmed Diagnostics

Guangzhou Kingmed Diagnostics Group Co., Ltd. announced that shareholder Guochuang Kaiyuan Equity Investment Fund (Limited Partnership) plans to reduce its stake in the company. Guochuang Kaiyuan, currently holding 30,880,905 shares or 6.67% of the company's total share capital, intends to reduce its holdings by no more than 4,632,582 shares, representing 1.00% of the total share capital, via centralized bidding. The reduction is motivated by the shareholder's own funding needs. The reduction period is planned from July 30, 2025, to October 29, 2025. Guochuang Kaiyuan obtained the shares prior to the company's IPO. Guochuang Kaiyuan has committed to informing the company in advance of any off-market share reductions. The company also stated that the proposed reduction will not change control of the company.